Company Profile

KVUE insider trades (13 months) →

Today's multi-factor rank: 315 of 466 · see the ranking

Quant500 Scores

Momentum

4.4/10

Value

4.9/10

Growth

4.5/10

Quality

5.0/10

Multifactor

4.7/10

Market and Valuation

Price & Market

Prev Close Price:$17.87

Open:$17.80

Day's Low:$17.76

Day's High:$17.97

Bid / Ask:-

Market Cap:34.21B

Enterprise Value:41.71B

52-Week Range

52-Week Low:$14.02

52-Week High:$20.13

Current position in 52-week range

52w Low-52w High

50-Day Avg:$18.94

200-Day Avg:$18.00

Volume

Volume Today:26,706,109

Avg Volume (3m):22,925,124

Avg Volume (10d):33,867,050

52-Week Change:+5.30%

vs S&P 500, 52 weeks:-

Beta:0.43

Valuation Multiples

PER Trailing:20.95

PER Forward:14.37

PEG Ratio:1.42

Price / Book:3.24

Price / Sales (TTM):2.22

EV / Revenue:2.71

EV / EBITDA:11.98

Dividends

Current yield:4.70%

Annual Dividend Rate:$0.84

Dividend Trailing:$0.83

Yield Trailing:4.64%

5-Year Avg Yield:-

Payout Ratio:97.65%

Last Ex-Dividend Date:-

Valuation Context

P/E vs sector (indicative)

Most Recent Quarter:-

Fiscal Year (Next):-

Date Filter (Month):

Loading historical OHLCV database...

Financial Statements TTM (Trailing 12 Months)

Income Statement

Total Revenue (TTM):15.41B

Gross Profit:9.00B

EBITDA:3.48B

Net Income (TTM):1.66B

Rev Growth (YoY):+3.00%

Earnings Growth (YoY):+8.50%

Quarterly earnings growth (YoY):+8.60%

Margins

Gross Margin:-

EBITDA Margin:-

Operating Margin:-

Net Margin:-

Per Share

EPS Trailing (TTM):-

EPS Forward (Est.):$1.24

Revenue Per Share:$8.04

Cash Per Share:-

Book Value:$5.50

Last Dividend:-

Ex-Dividend Date:-

Last Split:-

Balance Sheet & Liquidity

Total cash:1.11B

Total Debt:8.61B

Net Debt (Debt - Cash):7.50B

Debt / Equity:81.62%

Current Ratio:1.01

Quick Ratio:0.61

Cash Flows

Operating Cash Flow:2.32B

Free Cash Flow (FCF):1.91B

FCF Yield (FCF / Market Cap):-

Enterprise Value:41.71B

EV / Revenue:2.71

EV / EBITDA:11.98

Profitability

ROE (Return on Equity):15.58%

ROA (Return on Assets):6.99%

PER Trailing:20.95

PER Forward:14.37

Price / Book:3.24

PEG Ratio:1.42

52-Week Change:+5.30%

S&P 500 change, 52 weeks:+14.80%

Historical Evolution (Last 4 Years)

Income Statement

Balance Sheet

Cash Flow

EPS and Earnings Per Share

Key EPS Metrics

EPS Trailing (TTM):$0.85

EPS Forward (Est.):$1.24

PER Forward:-

PEG Ratio:1.42

Growth and Margins

Earnings Growth YoY:-

Quarterly Earnings Growth YoY:-

Rev Growth YoY:-

Net Margin:-

Gross Margin:-

EBITDA Margin:-

Per Share

Revenue Per Share:$8.04

Cash Per Share:-

Book Value:$5.50

Cash Flows (TTM)

Free Cash Flow:1.91B

Operating Cash Flow:2.32B

EBITDA:3.48B

Total Revenue (TTM):15.41B

Net Income (TTM):1.66B

Fiscal Year (Last):-

EPS Surprise History - Last 4 Quarters

Actual vs. Analyst Estimates · Green = beat expectations · Red = missed

Quarter	Period	Actual EPS	Estimated EPS	Difference	Surprise %	Currency

Ownership Structure

Ownership Distribution

% Insiders:-

% Institutional:-

% Inst. (of Float):-

No. of Institutions:-

Visual distribution

InsidersInstitutionalFree Float

Shares & Short Interest

Shares Outstanding:1,920,773,467

Float (free shares):1,918,142,007

Short interest (shares):72,137,384

Short % of float:-

Short Ratio (days to cover):3.40

Short interest, prior month:-

Short Interest Date:-

Governance Score (1=Best, 10=Worst)

Overall risk:-

Audit Risk:-

Board risk:-

Compensation Risk:-

Shareholder rights risk:-

Top Institutional Holders

Position Change: ▲ Increased · ▼ Reduced · = Unchanged

Organization	Report Date	% Shares	No. Shares	Value (USD)	Change %

Top Mutual Funds

Position Change: ▲ Increased ▼ Decreased = Unchanged

Fund	Report Date	% Shares	No. Shares	Value (USD)	Change %

Recent Insider Trades

Executive / Insider	Title	Date	Action	Shares

Options Chain

Expiration Date:

CALLS

Strike	Last	Bid	Ask	Vol.	O.I.	IV

PUTS

Strike	Last	Bid	Ask	Vol.	O.I.	IV

Kenvue Inc. (KVUE) SEC filings: 10-K, 10-Q and 8-K

Direct links to financial reports filed with the SEC.

Type	Date	Official link
10-Q	2026-08-06	View filing ↗
SD	2026-05-28	View filing ↗
8-K	2026-05-22	View filing ↗
10-Q	2026-05-07	View filing ↗
8-K	2026-04-15	View filing ↗
DEFA14A	2026-04-08	View filing ↗
10-K	2026-02-20	View filing ↗
8-K	2026-02-17	View filing ↗
8-K	2026-02-12	View filing ↗
8-K	2026-01-29	View filing ↗

Company and Executive Profile

Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.

General Information

Headquarters:United States

City:Summit

Employees:21,780

Sector:Consumer Defensive

Industry:Household & Personal Products

Website:-

Key Executives

Name	Title	Age	Total pay
Mr. Kirk L. Perry	CEO & Director	58	2.94M
Mr. Michael P. Wondrasch	Chief Technology & Data Officer	56	1.02M
Mr. Matthew Orlando	General Counsel	48	1.25M
Mr. Carlton Lawson	Group President of Europe, Middle East & Africa	56	1.41M
Ms. Heather R. Howlett	Interim CFO & Chief Accounting Officer	47	-
Ms. Meredith Stevens	Chief Operations Officer	62	1.83M
Dr. Caroline Tillett Ph.D.	Chief Scientific Officer	53	-
Ms. Sofya Tsinis	Head of Investor Relations	-	-

You have seen the engine room

Few finance sites let you get this far, and none we know of also shows you where its knowledge ends. If this way of working convinces you, the thing almost nobody catches in time can reach you by email: the big insider buys — executives and major shareholders putting in their own money — the same day they report them to the SEC, with the Form 4 linked. It takes three steps and none of them costs anything: create the account, confirm the email we send you, then switch the alert on in your profile (the icon at the top right). It starts off and it goes off again with the same click. Along the way all three are saved: your simulator portfolios, your personal portfolio and your Academy progress, synced across devices.

No card. No spam.

Kenvue Inc. (KVUE): Quantitative Analysis

Name: Factor scores for Kenvue Inc. (KVUE)
Creator: Quant500
License: https://quant500.com/legal

Kenvue Inc. (KVUE) — Consumer Defensive — Household & Personal Products. KVUE is in the S&P 500 today. Model factor scores and market data, recalculated every trading day.

So far in 2026, KVUE has returned +6.9% against +12.2% for the S&P 500 (SPY): total return, dividends included on both sides, from Dec 31, 2025 to Sep 18, 2026.

KVUE ranks 315 of 466 on today's multifactor score, and 15 of the 31 Consumer Defensive companies that score. Its strongest factor is quality (Z -0.01, ranked 220 of 473); its weakest is momentum (Z -0.35, ranked 298 of 497). Each factor ranks only the companies with data for it, and the multifactor score only those with all four: that is why the totals differ.

Factor scores

The Z-Score is how many standard deviations the company sits from the index average: 0 is average, positive is better than average, negative is worse.

Factor	Z-Score	Rank
Multifactor	-0.176	315 of 466 ↑1
Momentum	-0.348	298 of 497 ↑5
Value	-0.036	215 of 494 ↓3
Quality	-0.014	220 of 473 =
Growth	-0.306	341 of 494 =

Market data

Metric	Value
Price	$17.81
Market Cap	34.21B
P/E	20.95
Revenue (last 12 months)	15.41B
Price / book	3.24
Book value per share	$5.50
52-week range	$14.02 – $20.13
Dividend yield	4.70%
Beta	0.43
Average volume	22,925,124
Shares outstanding	1.92B
Short interest (% of float)	4.35% (as of Aug 31, 2026)

When does KVUE report earnings? 9 of its last 10, before the open →

What are KVUE insiders doing? 53 transactions filed with the SEC, of them 2 buys and 2 sells, the last one on Jul 31, 2026 →

Data as of Sep 18, 2026. Source: point-in-time SEC fundamentals and closing prices. Method and formulas are on the home page.

Company Profile

Market and Valuation

Price & Market

52-Week Range

Volume

Valuation Multiples

Dividends

Valuation Context

Financial Statements TTM (Trailing 12 Months)

Income Statement

Margins

Per Share

Balance Sheet & Liquidity

Cash Flows

Profitability

Historical Evolution (Last 4 Years)

Income Statement

Balance Sheet

Cash Flow

EPS and Earnings Per Share

Key EPS Metrics

Growth and Margins

Per Share

Cash Flows (TTM)

EPS Surprise History - Last 4 Quarters

Ownership Structure

Ownership Distribution

Shares & Short Interest

Governance Score (1=Best, 10=Worst)

Top Institutional Holders

Top Mutual Funds

Recent Insider Trades

Options Chain

CALLS

PUTS

Sentiment Metrics

Expected move

Kenvue Inc. (KVUE) SEC filings: 10-K, 10-Q and 8-K

Company and Executive Profile

General Information

Key Executives

You have seen the engine room

Kenvue Inc. (KVUE): Quantitative Analysis

Factor scores

Market data